| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Common Stock | Options Exercise | $770,340 | +33,654 | +41% | $22.89 | 116,473 | 25 Feb 2023 | Direct | F1 |
| transaction | PFE | Common Stock | Tax liability | $328,572 | -7,870 | -6.8% | $41.75 | 108,603 | 25 Feb 2023 | Direct | F2, F3 |
| transaction | PFE | Common Stock | Tax liability | $650,123 | -14,966 | -14% | $43.44 | 93,637 | 25 Feb 2023 | Direct | F4, F5 |
| holding | PFE | Common Stock | 5,973 | 25 Feb 2023 | By Rule 16b-3 Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -33,654 | -100% | $0.000000* | 0 | 25 Feb 2023 | Common Stock | 33,654 | $22.89 | Direct |
| Id | Content |
|---|---|
| F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
| F3 | Price is the closing price of Pfizer common stock on February 24, 2023. |
| F4 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F5 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |